MyFinsight
Home
Blog
About
Contact
Download
Download image
Proceeds from common
stock issued pursuant...
$4,534,053
Proceeds from revolving
line of credit
$2,924,000
Proceeds from common
stock issued pursuant...
$2,271,065
Proceeds from term loan
$228,448
Net cash provided by
(used in) financing...
$5,165,138
Canceled cashflow
$4,792,428
Net change in cash
and cash...
$3,808,724
Canceled cashflow
$1,356,414
Repayment of revolving
line of credit
$3,930,015
Repayment of merchant cash
advance
-$599,770
Offering costs
-$262,643
Stock-based compensation
$25,730,184
Inventories
-$1,539,243
Loss on debt
extinguishment
-$1,353,663
Accrued expenses and
other liabilities
$1,152,507
Accounts receivable
-$996,923
Accounts payable
$960,046
Amortization
$763,065
Amortization of debt discount
$406,371
Due from / to related
parties, net
-$134,977
Allowances for credit
losses
$65,128
something is missing
$65,001
Operating lease
liabilities, net
$62,035
Depreciation
$39,731
Net cash (used in)
provided by operating...
-$1,135,329
Net cash used in
investing activities
-$221,085
Canceled cashflow
$33,268,874
something is missing
$39,103,367
Net loss
-$34,318,204
Investments in capitalized
software
$221,085
Canceled cashflow
$39,103,367
Deposits
-$65,000
Other assets
$20,999
Net revenues
$21,667,212
Net loss before
income taxes
-$73,421,571
Gross profit
$1,429,405
Other income
$33,002
Canceled cashflow
$20,237,807
Loss from operations
-$68,397,073
Total other expense,
net
-$5,024,498
Canceled cashflow
$1,429,405
Canceled cashflow
$33,002
Cost of net revenues
$20,237,807
Total operating
expenses
$69,826,478
Interest expense, net
$3,703,837
Loss on debt
extinguishment
-$1,353,663
General and
administrative
$66,205,669
Depreciation and
amortization
$2,408,462
Sales and marketing
$1,212,347
Back
Back
Cash Flow
source: myfinsight.com
Wellgistics Health, Inc. (WGRX)
Wellgistics Health, Inc. (WGRX)